Ovarian Hyperstimulation Syndrome
📧 Sign up to get email alerts when something new happens for Ovarian Hyperstimulation Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating cabergoline for coasting to reduce the incidence of ovarian hyperstimulation syndrome; the study is c…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis [Phase 2]
Phase 2 clinical trial evaluating assessment and prevention of pain during ovarian stimulation in patients with endometriosis; results have …
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin [NA]
Completed comparative clinical trial assessing calcium gluconate with diosmin versus cabergoline regimens (with and without diosmin) for ova…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Ovarian Hyperstimulation Syndrome Prevention [NA]
This clinical trial update notes that recruitment is ongoing for a study focused on preventing ovarian hyperstimulation syndrome.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: The Letrozole Administration During Luteal Phase [Phase 3]
Phase 3 trial investigating letrozole administration during the luteal phase for a condition related to ovarian hyperstimulation syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome [Phase 4]
Phase 4 clinical trial update for IVF patients at high risk of ovarian hyperstimulation syndrome.
-
CLINICAL_TRIALS research · 2021-04-01Clinical Trial Update: Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders [Phase 4]
A Phase 4 trial update comparing GnRH agonist versus estrogen and progesterone for luteal support in high responders undergoing fertility tr…
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response [Phase 2]
Phase 2 clinical trial update on managing ovarian hyperstimulation syndrome via defective mineralocorticoid response.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS [Phase 4]
Phase 4 trial comparing coasting versus antagonist protocol in patients at high risk of ovarian hyperstimulation syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: CuMulativE Live bIrth Rate of Patients at High Risk of OHSS After Freeze-all Embryos at Cleavage or blAstocyst Stage [NA]
A clinical trial update reports on cumulative live birth rates for patients at high risk of ovarian hyperstimulation syndrome who underwent …
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome [Phase 2]
Phase 2 trial comparing cabergoline to calcium gluconate infusion for prevention of ovarian hyperstimulation syndrome (OHSS) has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation [Phase 4]
Phase 4 clinical trial update evaluating gene expression after GnRH agonist trigger of oocyte maturation; terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers [Phase 3]
Phase 3 trial evaluating cabergoline for prevention of ovarian hyperstimulation syndrome (OHSS) in IVF cycles completed.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: The Influence of Timing of Cabergoline Initiation on Prevention of OHSS [Phase 3]
A Phase 3 trial evaluating whether the timing of cabergoline initiation affects the prevention of ovarian hyperstimulation syndrome; the stu…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention [Phase 3]
Phase 3 trial comparing cabergoline versus calcium infusion for prevention of ovarian hyperstimulation syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos [NA]
A completed clinical trial studied implantation enhancement through elective cryopreservation of all viable embryos.
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS [Phase 4]
Phase 4 trial assessing co-administration of low-dose hCG with GnRH agonist trigger for prevention of OHSS; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Cabergoline and Coasting to Prevent OHSS [NA]
A Cairo University–sponsored clinical trial evaluating cabergoline and coasting to prevent ovarian hyperstimulation syndrome has completed.
-
CLINICAL_TRIALS research · 2017-06-15Clinical Trial Update: Preventive Application of GnRH Antagonist on Early OHSS [Phase 4]
Phase 4 clinical trial update examining preventive use of a GnRH antagonist to reduce early ovarian hyperstimulation syndrome; current statu…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
A completed clinical trial assessing controlled ovarian stimulation with HP-hMG in IVF/ICSI cycles focusing on ovarian hyperstimulation synd…
-
CLINICAL_TRIALS research · 2017-03-06Clinical Trial Update: Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET [Phase 3]
A Phase 3 clinical study update evaluating recombinant human follitropin for injection used for controlled ovarian hyperstimulation in assis…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]
A completed Phase 2/3 trial compared calcium dobesilate with cabergoline to prevent ovarian hyperstimulation syndrome in infertility treatme…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluates calcium dobesilate versus coasting for prevention of ovarian hyperstimulation syndrome in infert…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Vascular Cell Activation, Cell-Derived Microparticles and In Vitro Fertilisation, and In Vitro Fertilisation
A completed clinical trial from Poissy-Saint Germain Hospital examined vascular cell activation and cell-derived microparticles in the conte…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]
This clinical trial update reports outcomes of Cetrotide (cetrorelix) therapy to prevent ovarian hyperstimulation syndrome in women at high …